기관내 튜브 시장 인사이트, 경쟁 구도 및 시장 예측(-2034년)

Endotracheal Tubes Market Summary

• The global endotracheal tubes market is expected to increase from USD 2,021.76 million in 2025 to USD 3,691.85 million by 2034, reflecting strong and sustained growth.
• The global endotracheal tubes market is growing at a CAGR of 6.97% during the forecast period from 2026 to 2034.
• The market of endotracheal tubes is being primarily driven by the increasing prevalence of chronic respiratory disorders and cancer cases, the growing number of surgical procedures and ICU admissions, and the rising NICU and PICU admissions are collectively driving strong growth in the endotracheal tubes (ETTs) market by substantially increasing the demand for reliable airway management across all age groups. Chronic respiratory diseases and cancer often lead to respiratory failure or complex surgical interventions, requiring prolonged intubation and mechanical ventilation, while the rising volume of major surgeries and critical care admissions further elevates routine ETT usage in operating rooms and ICUs. At the same time, higher NICU and PICU admissions driven by preterm births, low birth weight, and congenital disorders are expanding demand for specialized neonatal and pediatric ETTs. Together, these factors are increasing both procedure volumes and per-patient ETT utilization, reinforcing the essential role of endotracheal tubes in acute, surgical, and critical care settings and accelerating overall market expansion.
• The leading companies operating in the endotracheal tubes market include Medtronic, Teleflex Incorporated, ConvaTec, Inc., Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., AirLife, Angiplast Pvt Ltd., Guangzhou Orcl Medical Co.,Ltd., Sumi, Van Oostveen Medical B.V., DEAS S.R.L, ICU Medical Inc., Sterimed Group, Respicare., Hangzhou BEVER Medical Devices Co., Ltd., Bryan Medical, Flexicare (Group) Limited, Viggo Medical Devices, and others.
• North America is expected to dominate the overall endotracheal tubes market due to the growing prevalence of chronic respiratory disorders and cancer cases, increased surgical procedures, and rising number of trauma and accident cases have boosted the overall market across the region.
• In the product type segment of the endotracheal tubes market, the reinforced category is estimated to account for the largest market share in 2025.

Key takeaways from the Endotracheal Tubes market report study

• Market size analysis for the current endotracheal tubes market size (2025), and market forecast for 8 years (2026 to 2034)
• Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
• Key companies dominating the endotracheal tubes market.
• Various opportunities available for the other competitors in the endotracheal tubes market space.
• What are the top-performing segments in 2025? How these segments will perform in 2034?
• Which are the top-performing regions and countries in the current endotracheal tubes market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for the endotracheal tubes market growth in the future?

Frequently Asked Questions for the Endotracheal Tubes Market

1. What is the growth rate of the endotracheal tubes market?

• The endotracheal tubes market is estimated to grow at a CAGR of 6.97% during the forecast period from 2026 to 2034.

2. What is the market for endotracheal tubes?

• The global endotracheal tubes market is expected to increase from USD 2,021.76 million in 2025 to USD 3,691.85 million by 2034.

3. Which region has the highest share in the endotracheal tubes market?

• North America is expected to account for the highest proportion of 35.69% of the endotracheal tubes market in 2025, out of all regions. This domination is due to the growing prevalence of chronic respiratory disorders and cancer cases, increased surgical procedures, and rising number of trauma and accident cases have boosted the overall market across the region.

4. What are the drivers for the Endotracheal Tubes market?

• The market of endotracheal tubes is being primarily driven by the increasing prevalence of chronic respiratory disorders and cancer cases, the growing number of surgical procedures and ICU admissions, and the rising NICU and PICU admissions are collectively driving strong growth in the endotracheal tubes (ETTs) market by substantially increasing the demand for reliable airway management across all age groups. Chronic respiratory diseases and cancer often lead to respiratory failure or complex surgical interventions, requiring prolonged intubation and mechanical ventilation, while the rising volume of major surgeries and critical care admissions further elevates routine ETT usage in operating rooms and ICUs. At the same time, higher NICU and PICU admissions driven by preterm births, low birth weight, and congenital disorders are expanding demand for specialized neonatal and pediatric ETTs. Together, these factors are increasing both procedure volumes and per-patient ETT utilization, reinforcing the essential role of endotracheal tubes in acute, surgical, and critical care settings and accelerating overall market expansion.

5. Who are the key players operating in the endotracheal tubes market?

• Some of the key market players operating in the endotracheal tubes market include Medtronic, Teleflex Incorporated, ConvaTec, Inc., Vygon, N8 Medical, LLC, Novo Klinik-Service GmbH, Intersurgical Ltd., AirLife, Angiplast Pvt Ltd., Guangzhou Orcl Medical Co.,Ltd., Sumi, Van Oostveen Medical B.V., DEAS S.R.L, ICU Medical Inc., Sterimed Group, Respicare., Hangzhou BEVER Medical Devices Co., Ltd., Bryan Medical, Flexicare (Group) Limited, Viggo Medical Devices, and others.

Table of Contents

1. Endotracheal Tubes Market Report Introduction

• 1.1 Scope of the Study
• 1.2 Market Segmentation
• 1.3 Market Assumption

2. Endotracheal Tubes Market Executive Summary

• 2.1 Market at Glance

3. Endotracheal Tubes Market Key Factors Analysis

• 3.1 Endotracheal Tubes Market Drivers
  • 3.1.1 Increasing prevalence of chronic respiratory disorders and cancer cases
  • 3.1.2 Increasing number of surgical procedures and ICU admission
  • 3.1.3 Rising NICU and PICU admissions
• 3.2 Endotracheal Tubes Market Restraints and Challenges
  • 3.2.1 Risk of complication during insertion of endotracheal tubes
  • 3.2.2 Increased number of product recalls due to safety
• 3.3 Endotracheal Tubes Market Opportunity
  • 3.3.1 Development of safer and technologically advanced endotracheal tubes

4. Impact Analysis

• 4.1 AI-Powered Innovations and Applications
• 4.2 U.S. Tariff Impact Analysis

5. Regulatory Analysis

• 5.1 The United States
• 5.2 Europe
• 5.3 Japan
• 5.4 China

6. Endotracheal Tubes Market Porter's Five Forces Analysis

• 6.1 Bargaining Power of Suppliers
• 6.2 Bargaining Power of Consumers
• 6.3 Threat of New Entrants
• 6.4 Threat of Substitutes
• 6.5 Competitive Rivalry

7. Endotracheal Tubes Market Assessment

• 7.1 By Product Type
  • 7.1.1 Standard
  • 7.1.2 Reinforced
  • 7.1.3 Coated
  • 7.1.4 Others
• 7.2 By Cuff Type
  • 7.2.1 Cuffed
  • 7.2.2 Uncuffed/Cuffless
• 7.3 By Intubation Route
  • 7.3.1 Oral
  • 7.3.2 Nasal
• 7.4 By Age Group
  • 7.4.1 Adults
  • 7.4.2 Pediatrics
• 7.5 By End-Users
  • 7.5.1 Hospitals
  • 7.5.2 Ambulatory Surgical Centers
  • 7.5.3 Others
• 7.6 By Geography
  • 7.6.1 North America
    • 7.6.1.1 United States Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.1.2 Canada Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.1.3 Mexico Endotracheal Tubes Market Size in USD million (2023-2034)
  • 7.6.2 Europe
    • 7.6.2.1 France Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.2.2 Germany Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.2.3 United Kingdom Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.2.4 Italy Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.2.5 Spain Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.2.6 Rest of Europe Endotracheal Tubes Market Size in USD million (2023-2034)
  • 7.6.3 Asia-Pacific
    • 7.6.3.1 China Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.3.2 Japan Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.3.3 India Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.3.4 Australia Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.3.5 South Korea Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.3.6 Rest of Asia-Pacific Endotracheal Tubes Market Size in USD million (2023-2034)
  • 7.6.4 Rest of the World (RoW)
    • 7.6.4.1 Middle East Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.4.2 Africa Endotracheal Tubes Market Size in USD million (2023-2034)
    • 7.6.4.3 South America Endotracheal Tubes Market Size In USD Million (2023-2034)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Endotracheal Tubes Market Company and Product Profiles

• 10.1 Medtronic
  • 10.1.1 Company Overview
  • 10.1.2 Company Snapshot
  • 10.1.3 Financial Overview
  • 10.1.4 Product Listing
  • 10.1.5 Entropy
• 10.2 Teleflex Incorporated
  • 10.2.1 Company Overview
  • 10.2.2 Company Snapshot
  • 10.2.3 Financial Overview
  • 10.2.4 Product Listing
  • 10.2.5 Entropy
• 10.3 ConvaTec, Inc.
  • 10.3.1 Company Overview
  • 10.3.2 Company Snapshot
  • 10.3.3 Financial Overview
  • 10.3.4 Product Listing
  • 10.3.5 Entropy
• 10.4 Vygon
  • 10.4.1 Company Overview
  • 10.4.2 Company Snapshot
  • 10.4.3 Financial Overview
  • 10.4.4 Product Listing
  • 10.4.5 Entropy
• 10.5 N8 Medical, LLC
  • 10.5.1 Company Overview
  • 10.5.2 Company Snapshot
  • 10.5.3 Financial Overview
  • 10.5.4 Product Listing
  • 10.5.5 Entropy
• 10.6 Novo Klinik-Service GmbH
  • 10.6.1 Company Overview
  • 10.6.2 Company Snapshot
  • 10.6.3 Financial Overview
  • 10.6.4 Product Listing
  • 10.6.5 Entropy
• 10.7 Intersurgical Ltd.
  • 10.7.1 Company Overview
  • 10.7.2 Company Snapshot
  • 10.7.3 Financial Overview
  • 10.7.4 Product Listing
  • 10.7.5 Entropy
• 10.8 AirLife
  • 10.8.1 Company Overview
  • 10.8.2 Company Snapshot
  • 10.8.3 Financial Overview
  • 10.8.4 Product Listing
  • 10.8.5 Entropy
• 10.9 Angiplast Pvt Ltd.
  • 10.9.1 Company Overview
  • 10.9.2 Company Snapshot
  • 10.9.3 Financial Overview
  • 10.9.4 Product Listing
  • 10.9.5 Entropy
• 10.10 Guangzhou Orcl Medical Co.,Ltd.
  • 10.10.1 Company Overview
  • 10.10.2 Company Snapshot
  • 10.10.3 Financial Overview
  • 10.10.4 Product Listing
  • 10.10.5 Entropy
• 10.11 Sumi
  • 10.11.1 Company Overview
  • 10.11.2 Company Snapshot
  • 10.11.3 Financial Overview
  • 10.11.4 Product Listing
  • 10.11.5 Entropy
• 10.12 Van Oostveen Medical B.V.
  • 10.12.1 Company Overview
  • 10.12.2 Company Snapshot
  • 10.12.3 Financial Overview
  • 10.12.4 Product Listing
  • 10.12.5 Entropy
• 10.13 DEAS S.R.L
  • 10.13.1 Company Overview
  • 10.13.2 Company Snapshot
  • 10.13.3 Financial Overview
  • 10.13.4 Product Listing
  • 10.13.5 Entropy
• 10.14 ICU Medical Inc.
  • 10.14.1 Company Overview
  • 10.14.2 Company Snapshot
  • 10.14.3 Financial Overview
  • 10.14.4 Product Listing
  • 10.14.5 Entropy
• 10.15 Sterimed Group
  • 10.15.1 Company Overview
  • 10.15.2 Company Snapshot
  • 10.15.3 Financial Overview
  • 10.15.4 Product Listing
  • 10.15.5 Entropy
• 10.16 Respicare.
  • 10.16.1 Company Overview
  • 10.16.2 Company Snapshot
  • 10.16.3 Financial Overview
  • 10.16.4 Product Listing
  • 10.16.5 Entropy
• 10.17 Hangzhou BEVER Medical Devices Co., Ltd.
  • 10.17.1 Company Overview
  • 10.17.2 Company Snapshot
  • 10.17.3 Financial Overview
  • 10.17.4 Product Listing
  • 10.17.5 Entropy
• 10.18 Bryan Medical
  • 10.18.1 Company Overview
  • 10.18.2 Company Snapshot
  • 10.18.3 Financial Overview
  • 10.18.4 Product Listing
  • 10.18.5 Entropy
• 10.19 Flexicare (Group) Limited
  • 10.19.1 Company Overview
  • 10.19.2 Company Snapshot
  • 10.19.3 Financial Overview
  • 10.19.4 Product Listing
  • 10.19.5 Entropy
• 10.20 Viggo Medical Devices
  • 10.20.1 Company Overview
  • 10.20.2 Company Snapshot
  • 10.20.3 Financial Overview
  • 10.20.4 Product Listing
  • 10.20.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us